Investment State-of-Play in Big Pharma: Bayer’s Eugene Borukhovich Weighs In
Bayer’s G4A team has just launched their 2019 program. Are you a startup interested in applying? A health tech innovator wondering what a big pharma co…
Live
The ‘State of Play’ in Big Pharma & Digital Health: Industry Expert Paul Tunnah of Pharmaphorum Weighs In
Pharma companies, the health industry’s original lovers of all things innovation, have embraced digital health with abandon over the past four years. A…
The New Business Model Behind Pharma’s Digital Disruption: Proteus Digital Health’s CEO Andrew Thompson
According to Andrew Thompson, CEO of Proteus Digital Health, the ‘digital era’ of pharma has begun His company – which has coined the term ‘Digital Me…
What future for pharma in a digital world?
Yesterday I joined 600 digital health innovators and experts at the first day of the Frontiers Health conference in Berlin’s historic Funkhaus radio st…
What is the Consumerization of Healthcare? Dr. Rasu Shrestha, Chief Innovation Officer of University of Pittsburgh Medical Center (UPMC)
Regardless of where in the world you’re working to transform the healthcare industry, you need to understand the ‘consumer health movement’ and how it’…
What’s Trending in Digital Health? A Global Perspective from Bayer G4A’s Zsuzsanna Varga
In her role leading global partnerships for Bayer G4A, Zsuzsanna Varga has reviewed more than 5,000 applications from startups looking to make their wa…
What’s Hot for Health Tech Investors? Marvin Liao from 500 Startups Weighs In
500 Startups is a Silicon Valley based VC fund/accelerator program known for helping tech startups make big exits. There was 3D Printing startup, Maker…